Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum.Giorgia Salvia,Matteo Bevilacqua,Flavia Manzo Margiotta,Alessandra Michelucci,Giammarco Granieri,Cristian Fidanzi,Valentina Dini,Marco Romanelli,Carlo MazzatentaThe Australasian journal of dermatology(2024)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要